Sandoz Recalls

Sandoz Cyclophosphamide Injection 500 mg/5 mL Recalled for Temperature Excursion During Transport

Sandoz Inc. recalled 263 vials of Cyclophosphamide injection distributed nationwide in the United States. The recall cites cGMP deviations due to a temperature excursion during transportation. Healthcare providers and patients should stop using the product and contact Sandoz for guidance.